ArticleFrontiers in public health2025
Influenza: temporal trends in mortality, hospitalization, and vaccination in the older adults population aged 60 and more years, Brazil, 2000-2023.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the temporal evolution of mortality rates, hospitalization, and vaccination coverage for influenza among the population ≥ 60 years of age in Brazil from 2000 to 2023. Methods A descriptive study with secondary and anonymous data from the Ministry of Health was collected year by year to calculate the rates. Data on the composition of the vaccines were also obtained. Results: The data pointed to: (1) an increase in deaths from influenza, especially during the COVID-19 pandemic, but a decrease in 2023 with the registration of 2.5 deaths per 100 thousand inhabitants; (2) reduction in hospitalizations for influenza, but increase during the Covid-19 pandemic and decrease in 2023, with a record of 22 hospitalizations per 100 thousand inhabitants; (3) linear growth in vaccination coverage, reaching 99.4% in 2019, exceeding 100% in 2020 and a sharp drop in subsequent years, reaching the lowest value in the series (63.3%) in 2023; and (4) formulation of vaccines containing three different strains in all campaigns. Conclusion: The impact of Covid-19 on mortality and hospitalization rates from 2020 beyond is evident. The role of the federal government in controlling pandemics and the importance of vaccination, among other measures, are highlighted. Currently, the challenge is to increase immunization against influenza, a disease with low mortality and hospitalization rates for the population of this study, but with high transmissibility in the general population, with an impact not only on health, but also on social and economic wealth.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.